BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11085983)

  • 41. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation.
    Gronda M; Arab S; Iafrate B; Suzuki H; Zanke BW
    Mol Cell Biol; 2001 Oct; 21(20):6851-8. PubMed ID: 11564869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
    Slack DN; Seternes OM; Gabrielsen M; Keyse SM
    J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The MAP kinases are differently utilized by CD28 and CD2 adhesion pathways in superantigen-activated Jurkat T cells.
    Visse E; Inostroza J; Cabello G; Parra E
    Biol Res; 2003; 36(2):263-78. PubMed ID: 14513721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zinc differentially regulates mitogen-activated protein kinases in human T cells.
    Hönscheid A; Dubben S; Rink L; Haase H
    J Nutr Biochem; 2012 Jan; 23(1):18-26. PubMed ID: 21333516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation.
    Yu CT; Shih HM; Lai MZ
    J Immunol; 2001 Jan; 166(1):284-92. PubMed ID: 11123304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells.
    Ghaffari-Tabrizi N; Bauer B; Villunger A; Baier-Bitterlich G; Altman A; Utermann G; Uberall F; Baier G
    Eur J Immunol; 1999 Jan; 29(1):132-42. PubMed ID: 9933094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28.
    Reinhold MI; Green JM; Lindberg FP; Ticchioni M; Brown EJ
    Int Immunol; 1999 May; 11(5):707-18. PubMed ID: 10330276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway.
    Charvet C; Auberger P; Tartare-Deckert S; Bernard A; Deckert M
    J Biol Chem; 2002 May; 277(18):15376-84. PubMed ID: 11859076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accumulation of RXR alpha during activation of cycling human T lymphocytes: modulation of RXRE transactivation function by mitogen-activated protein kinase pathways.
    Ishaq M; Fan M; Natarajan V
    J Immunol; 2000 Oct; 165(8):4217-25. PubMed ID: 11035054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reconstitution of T cell antigen receptor-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk.
    Williams S; Couture C; Gilman J; Jascur T; Deckert M; Altman A; Mustelin T
    Eur J Biochem; 1997 Apr; 245(1):84-90. PubMed ID: 9128727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells.
    Kim JE; White FM
    J Immunol; 2006 Mar; 176(5):2833-43. PubMed ID: 16493040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
    Pettiford SM; Herbst R
    Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
    Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H
    J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective induction of p38 mitogen-activated protein kinase activity following A6H co-stimulation in primary human CD4(+) T cells.
    Labuda T; Sundstedt A; Dohlsten M
    Int Immunol; 2000 Mar; 12(3):253-61. PubMed ID: 10700460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
    Whitehurst CE; Geppert TD
    J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
    Su MW; Yu CL; Burakoff SJ; Jin YJ
    J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation.
    Villalba M; Coudronniere N; Deckert M; Teixeiro E; Mas P; Altman A
    Immunity; 2000 Feb; 12(2):151-60. PubMed ID: 10714681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-interfering RNA-mediated Lck knockdown results in augmented downstream T cell responses.
    Methi T; Ngai J; Mahic M; Amarzguioui M; Vang T; Tasken K
    J Immunol; 2005 Dec; 175(11):7398-406. PubMed ID: 16301647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells.
    Sakata N; Kawasome H; Terada N; Gerwins P; Johnson GL; Gelfand EW
    Eur J Immunol; 1999 Sep; 29(9):2999-3008. PubMed ID: 10508274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.